Document is current
Any future updates will be listed below
-
Authors
Gwaltney, Chad https://orcid.org/0000-0001-8130-2024
Stokes, Jonathan
Aiudi, Anthony
Mazar, Iyar
Ollis, Sarah
Love, Emily
Karaa, Amel
Houts, Carrie R.
Wirth, R. J.
Shields, Alan L.
-
Funding
Funding for this research was provided by:
Stealth BioTherapeutics, Inc.
- License Information
-
More Information
Article History
Received: 17 June 2022
Accepted: 14 December 2022
First Online: 23 December 2022
Declarations
:
: All human studies described in this manuscript have been approved by the appropriate Ethics Committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All participating subjects in this trial gave their informed consent prior to their inclusion in the study.
: Not applicable.
: Design, study conduct, and financial support for the study were provided by Stealth BioTherapeutics Inc. Amel Karaa is the lead Principal Investigator on the MMPOWER program and has conducted clinical trials for the Stealth BioTherapeutics’ SPIMM trials.
